These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11876040)

  • 21. R&D technology investments: misguided and expensive or a better way to discover medicines?
    Schmid EF; Smith DA
    Drug Discov Today; 2006 Sep; 11(17-18):775-84. PubMed ID: 16935744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 23. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.
    Sonderholm J
    J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key factors in the rising cost of new drug discovery and development.
    Dickson M; Gagnon JP
    Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
    [No Abstract]   [Full Text] [Related]  

  • 26. [Reaction to 'Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry' and to 'The importance of public-private cooperation. Comment on Vandereycken'].
    Buis WM
    Tijdschr Psychiatr; 2006; 48(6):500-1; author reply 501-3. PubMed ID: 16956013
    [No Abstract]   [Full Text] [Related]  

  • 27. Payers growing influence on R&D decision making.
    Hughes B
    Nat Rev Drug Discov; 2008 Nov; 7(11):876-8. PubMed ID: 18974741
    [No Abstract]   [Full Text] [Related]  

  • 28. Patentees research and development expenditure in Canada.
    Li S; Tomalin A
    J Pharm Pharm Sci; 2002; 5(1):5-11. PubMed ID: 12042113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open innovation: chances and challenges for the pharmaceutical industry.
    Niedergassel B; Leker J
    Future Med Chem; 2009 Oct; 1(7):1197-200. PubMed ID: 21426095
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 31. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic fundamentals of the U.S. pharmaceutical market.
    Lybecker KM
    Manag Care; 2004 Jun; 13(6 Suppl):7-9; discussion 12-3, 41-2. PubMed ID: 15303519
    [No Abstract]   [Full Text] [Related]  

  • 34. Research or payoff?
    Morrison JB
    Tex Med; 2002 May; 98(5):10. PubMed ID: 12043388
    [No Abstract]   [Full Text] [Related]  

  • 35. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry].
    Vandereycken W
    Tijdschr Psychiatr; 2006; 48(2):119-29. PubMed ID: 16958195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the rise in American pharmaceutical prices.
    Marwaha A
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112
    [No Abstract]   [Full Text] [Related]  

  • 38. [The cheapest synonymous preparations--a proposal with unwanted consequences].
    Rytter E
    Tidsskr Nor Laegeforen; 1989 Nov; 109(32):3359-60. PubMed ID: 2595709
    [No Abstract]   [Full Text] [Related]  

  • 39. Examining the link between price regulation and pharmaceutical R&D investment.
    Vernon JA
    Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.